TY - JOUR
T1 - Management of patients who had undergone non-curative endoscopic submucosal dissection (ESD)/endoscopic mucosal resection (EMR) for early gastric cancer
AU - Hatta, Waku
AU - Gotoda, Takuji
AU - Oyama, Tsuneo
AU - Koike, Tomoyuki
AU - Masamune, Atsushi
AU - Shimosegawa, Tooru
N1 - Publisher Copyright:
© 2018 Japan Institute of Electronics Packaging. All rights reserved.
PY - 2018/6
Y1 - 2018/6
N2 - According to the guidelines established by the Japanese Gastric Cancer Association and Japan Gastroenterological Endoscopy Society, radical surgery is recommended for all patients who underwent non-curative endoscopic submucosal dissection (ESD)/endoscopic mucosal resection (EMR) for early gastric cancer (EGC) because of the potential risk of lymph node metastasis (LNM). However, 29-70% of patients who underwent non-curative ESD/EMR have been followed up with no additional treatment. In addition, the rate of LNM among patients who underwent radical surgery after non-curative ESD/EMR is 4-11% . The strongest independent risk factor for LNM in patients who underwent non-curative ESD is lymphatic invasion, and there are other independent risk factors such as venous invasion as well. We previously reported a simple scoring system for predicting LNM in patients who underwent non-curative ESD, which may provide useful information in clinical practice. Meanwhile, patients with gastric cancer have become older. Thus, the establishment of a prognostic model for predicting overall survival including cancer-related mortality in elderly patients who underwent non-curative ESD/EMR is required.
AB - According to the guidelines established by the Japanese Gastric Cancer Association and Japan Gastroenterological Endoscopy Society, radical surgery is recommended for all patients who underwent non-curative endoscopic submucosal dissection (ESD)/endoscopic mucosal resection (EMR) for early gastric cancer (EGC) because of the potential risk of lymph node metastasis (LNM). However, 29-70% of patients who underwent non-curative ESD/EMR have been followed up with no additional treatment. In addition, the rate of LNM among patients who underwent radical surgery after non-curative ESD/EMR is 4-11% . The strongest independent risk factor for LNM in patients who underwent non-curative ESD is lymphatic invasion, and there are other independent risk factors such as venous invasion as well. We previously reported a simple scoring system for predicting LNM in patients who underwent non-curative ESD, which may provide useful information in clinical practice. Meanwhile, patients with gastric cancer have become older. Thus, the establishment of a prognostic model for predicting overall survival including cancer-related mortality in elderly patients who underwent non-curative ESD/EMR is required.
UR - http://www.scopus.com/inward/record.url?scp=85049395955&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049395955&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85049395955
SN - 0387-1207
VL - 60
SP - 1173
EP - 1185
JO - Gastroenterological Endoscopy
JF - Gastroenterological Endoscopy
IS - 6
ER -